摘要
在过去的十年中,许多研究强调了代谢型谷氨酸受体亚型5(mGlu5)调节剂在减少酒精相关生物学效应(如酒精消耗,酒精寻求和复发样行为)中的作用。总之,这些研究结果表明,作用于mGlu5的药物可能是抑制醉酒的有前景的工具。 mGlu5s大量存在于已知参与情绪调节,动机和药物施用的大脑区域中。在细胞水平上,它们主要位于神经元的突触后部分,其中受体功能性连接至参与细胞信号传导和介导酒精诱导的神经可塑性的基因转录的各种下游蛋白质。同样,mGlu5与特定同功酶蛋白激酶Cε(PKCε)在介导mGlu5的选择性负变构调节剂如甲基-6(苯乙炔基)吡啶(MPEP)和3- ((2-甲基-4-噻唑基)乙炔基)吡啶(MTEP)引发了有趣的推测。在本文中,我们将回顾以下内容:急性和慢性酒精摄入对mGlu5信号传导的影响; mGlu5配体对酒精相关的神经行为改变的影响,目前正在临床前和临床阶段进行研究;以及这些药物药理作用的机制。
关键词: 钙调蛋白,乙醇,本垒打,mGlu5,突触后密度蛋白,酒精成瘾。
图形摘要
Current Drug Targets
Title:Alcohol Addiction- Metabotropic Glutamate Receptor Subtype 5 and its Ligands: How They All Come Together?
Volume: 19 Issue: 8
关键词: 钙调蛋白,乙醇,本垒打,mGlu5,突触后密度蛋白,酒精成瘾。
摘要: In the past decade, many studies have highlighted the role of metabotropic glutamate receptor subtype 5 (mGlu5) modulators in attenuating alcohol-related biological effects such as alcohol consumption, alcohol-seeking and relapse-like behaviors. Taken together, these findings suggest that pharmacological agents acting at mGlu5 could be promising tools in curbing inebriation. mGlu5s are present abundantly in brain regions known to be involved in emotion regulation, motivation and drug administration. On a cellular level, they are primarily located at the postsynaptic part of the neuron where the receptor is functionally linked to various downstream proteins that are involved in cell signaling and gene transcription that mediate the alcohol-induced neuroplasticity. As well, the discovery of a functional link between mGlu5 and a specific isozyme, Protein Kinase C epsilon (PKCε) in mediating the attenuating effects of selective negative allosteric modulators of mGlu5 such as methyl- 6(phenylethynyl)pyridine (MPEP) and 3-((2-methyl-4-thiazolyl)ethynyl)pyridine (MTEP) has sparked interesting speculations. In this article, we shall review the following: the effects of acute and chronic alcohol intake on mGlu5 signaling; the effects of mGlu5 ligands on alcohol-related neurobehavioral changes that are currently being studied both at pre-clinical and clinical stages; and the mechanisms underlying the pharmacological effects of these drugs.
Export Options
About this article
Cite this article as:
Alcohol Addiction- Metabotropic Glutamate Receptor Subtype 5 and its Ligands: How They All Come Together?, Current Drug Targets 2018; 19 (8) . https://dx.doi.org/10.2174/1389450118666170511144302
DOI https://dx.doi.org/10.2174/1389450118666170511144302 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Books

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Natural and Synthetic Compounds with an Antimycobacterial Activity
Mini-Reviews in Organic Chemistry Lysophospholipase D/Autotaxin in Lysophospholipid Biology
Current Enzyme Inhibition Chemotherapy-Induced Peripheral Neuropathic Pain and Rodent Models
CNS & Neurological Disorders - Drug Targets HIV-1 Vpu Interference with Innate Cell-mediated Immune Mechanisms
Current HIV Research Mechanistic Studies of the Process of Amyloid Fibrils Formation by the Use of Peptide Fragments and Analogues: Implications for the Design of Fibrillization Inhibitors
Current Medicinal Chemistry Excitability of Dopamine Neurons: Modulation and Physiological Consequences
CNS & Neurological Disorders - Drug Targets Use of Toll-Like Receptor 3 Agonists Against Respiratory Viral Infections
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Pharmacology of the Neurochemical Transmission in the Midbrain Raphe Nuclei of the Rat
Current Neuropharmacology Prodrug Design of Phenolic Drugs
Current Pharmaceutical Design Ganglioside GD3 as a Raft Component in Cell Death Regulation
Anti-Cancer Agents in Medicinal Chemistry Cardioprotective Effects of the I<sub>f</sub> Current Inhibition by Ivabradine During Cardiac Dysfunction
Current Pharmaceutical Biotechnology The Role of Melatonin in the Immuno-Neuro-Psychology of Mental Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Acknowledgements
Current Alzheimer Research Mechanism-Based Inactivation of Cytochrome P450 Enzymes: Chemical Mechanisms, Structure-Activity Relationships and Relationship to Clinical Drug-Drug Interactions and Idiosyncratic Adverse Drug Reactions
Current Drug Metabolism Treatment-resistant Late-life Depression: Challenges and Perspectives
Current Neuropharmacology Role of C1QBP/p32 and its Therapeutic Potential in Breast Carcinoma and other Cancers
Current Medicinal Chemistry Bio-AIMS Collection of Chemoinformatics Web Tools based on Molecular Graph Information and Artificial Intelligence Models
Combinatorial Chemistry & High Throughput Screening Raf Inhibitors as Therapeutic Agents Against Neurodegenerative Diseases
CNS & Neurological Disorders - Drug Targets Heat Shock Protein 90 Inhibitors as Therapeutic Agents
Recent Patents on Anti-Cancer Drug Discovery Xanthine Oxidoreductase in Drug Metabolism: Beyond a Role as a Detoxifying Enzyme
Current Medicinal Chemistry